Inhibitor Therapeutics, Inc. (OTCMKTS:INTI – Get Free Report) was the target of a significant increase in short interest in February. As of February 28th, there was short interest totalling 53,900 shares, an increase of 36.8% from the February 13th total of 39,400 shares. Based on an average trading volume of 100 shares, the short-interest ratio is presently 539.0 days. Approximately 0.0% of the company’s shares are sold short.
Inhibitor Therapeutics Price Performance
Shares of Inhibitor Therapeutics stock remained flat at $0.07 during trading on Friday. 13,727 shares of the company traded hands, compared to its average volume of 38,647. The firm has a market capitalization of $12.06 million, a P/E ratio of -7.00 and a beta of -0.55. The business’s 50 day moving average price is $0.06 and its two-hundred day moving average price is $0.07. Inhibitor Therapeutics has a 52 week low of $0.04 and a 52 week high of $0.14.
About Inhibitor Therapeutics
Read More
- Five stocks we like better than Inhibitor Therapeutics
- Pros And Cons Of Monthly Dividend Stocks
- How to Build the Ultimate Everything ETF Portfolio
- Most Volatile Stocks, What Investors Need to Know
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How to trade using analyst ratings
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Inhibitor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inhibitor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.